Pharmaceuticals
Forest Labs acquires Aptalis for $2.9 bn
09 Jan 2014
The acquisition of Aptalis will help diversify Forest's pharmaceuticals portfolio while advancing its strategy to create blockbuster therapeutics
Thermo Fischer to sell cell research business to GE for over $1 bn
07 Jan 2014
The world’s second-largest laboratory equipment and supplies provider Thermo Fischer Scientific Inc will sell its cell research business to GE Healthcare for $1.06 billion,to gain EC’s approval for is acquisition of rival Life Technologies
Drug companies in UK not sharing complete information on clinical trials with doctors: MPs
04 Jan 2014
Sanofi fails to win US FDA approval for Genzyme's MS drug Lemtrada
30 Dec 2013
The drug, which gained approval in the EU in September, and in Australia and Canada this month, formed a key part of Sanofi’s $20.1-billion acquisition of Genzyme in 2011
AstraZeneca to acquire Bristol-Myers Squibb’s stake in diabetes business
20 Dec 2013
The acquisition will boost AstraZeneca's presence in the emerging markets, where diabetes is a fast-growing problem and by 2030, is expected to accout of two-thirds of the world's diabetic population
S Korean companies Hanmi and Amneal Pharm launch first copy of AstraZeneca's Nexium in US
20 Dec 2013
Bayer to acquire cancer drug maker Algeta
19 Dec 2013
Bayer and Algeta are partners in the sale of the prostate cancer drug Xofigo, which the US FDA had approved in May
.webp)
.webp)
